Mariyana Atanasova - Concepedia

Author

Mariyana Atanasova

Also Known As

Atanasova, Mariyana, M ATANASOVA, M Atanasova, M P Atanasova, M. Atanasova, M. P. Atanasova, MARIYANA ATANASOVA, Mariana Atanasova, Mariyana Atanasova

Publications

849

Citations

H-Index

Concepts

All Affiliations

Medical University of Sofia Bulgarian Academy of Sciences Institute of Organic Chemistry with Centre of Phytochemistry Institute of Biodiversity and Ecosystem Research Sofia University "St. Kliment Ohridski"

About

Mariyana Atanasova is an author at Medical University of Sofia specializing in medicine, natural sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	433
2	Natural Sciences	7	7	254
3	Biochemistry	6	6	301
4	Chemical Biology	3	3	122
5	Engineering	1	1	67

Mariyana Atanasova

Publications

751

Citations

H-Index

Page 1

	Year	Citations
Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity Mariyana Atanasova, Georgi Stavrakov, Irena Philipova, Bioorganic & Medicinal Chemistry Combinatorial ChemistryAcetylcholinesterase Inhibitory ActivityBiochemistryMedicineGalantamine Derivatives	2015	88
QSAR analysis of 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines with anticancer activity Mariyana Atanasova, Sonia Ilieva, Boris Galabov European Journal of Medicinal Chemistry Medicinal ChemistryQsar AnalysisBiochemistryNatural SciencesMedicine	2007	69
EpiDOCK: a molecular docking-based tool for MHC class II binding prediction Mariyana Atanasova, Atanas Patronov, Ivan Dimitrov, Protein Engineering Design and Selection EngineeringImmunologyMolecular BiologyImmunodominanceAntigen Processing	2013	67
Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study Irini Doytchinova, Mariyana Atanasova, Evdokiya Salamanova, Biomolecules	2020	64
A role of salt bridges in mediating drug potency: A lesson from the N-myristoyltransferase inhibitors Danislav S. Spassov, Mariyana Atanasova, Irini Doytchinova Frontiers in Molecular Biosciences Drug TargetMolecular BiologyPharmacotherapySystem PharmacologyChemical Biology	2023	60
Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors Georgi Stavrakov, Irena Philipova, Atanas Lukarski, Molecules	2020	42
Novel hits for acetylcholinesterase inhibition derived by docking-based screening on ZINC database Irini Doytchinova, Mariyana Atanasova, Iva Valkova, Journal of Enzyme Inhibition and Medicinal Chemistry Drug TargetHit IdentificationNovel HitsBbb PermeabilityLead Identification	2018	37
Molecular Docking Study on Galantamine Derivatives as Cholinesterase Inhibitors Mariyana Atanasova, Nikola Yordanov, Ivan Dimitrov, Molecular Informatics	2015	33
A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders Rumyana Simeonova, Dimitrina Zheleva‐Dimitrova, Iva Valkova, Molecules	2021	30
Docking-based Design of Galantamine Derivatives with Dual-site Binding to Acetylcholinesterase Georgi Stavrakov, Irena Philipova, Dimitrina Zheleva‐Dimitrova, Molecular Informatics Combinatorial ChemistryBioorganic ChemistryPeptide ScienceChemical BiologyPharmaceutical Chemistry	2016	25

Page 1